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6,600–4,500 years before present, confirmed the relatively 
high frequency of this haplotype in the region, and (3) no 
functional differences between this haplotype and wild-
type  TLR4 have been found. In contrast, the disappearance 
of the 299Gly/399Thr haplotype in Europe is most likely due 
to negative selection due to sepsis. In conclusion, differenc-
es in distribution of  TLR4 polymorphisms Asp299Gly and 
Thr399Ile in European populations are most likely due to a 
combination of population migration events combined with 
selection due to sepsis.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Genes encoding proteins important for host defense 
against infections are constantly exposed to pressures 
from infectious diseases, suggesting that pathogenic mi-
croorganisms are one of the most important evolutionary 
selective forces shaping our genome during human his-
tory  [1, 2] . Selection among immunity genes, both posi-
tive and balancing natural selection, is relatively more 
commonly found compared to other gene classes  [1] . The 
first step of the host response during infection is repre-
sented by the recognition of conserved structures of bac-
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 Abstract 
 Infections exert important evolutionary pressures shaping 
the human genome, especially on genes involved in host de-
fense. A crucial step for host defense is recognition of patho-
gens by pattern recognition receptors on innate immune 
cells, among which Toll-like receptor 4  (TLR4) is one of the 
best known. Genetic variation in  TLR4 (Asp299Gly, Thr399Ile) 
has been recently described. Haplotype frequencies of these 
polymorphisms differ among African, Asian and European 
populations, suggesting evolutionary pressures exerted by 
local infections. The  TLR4 299Gly/399Ile haplotype, charac-
teristic mainly of European populations, has relatively high 
frequency in the Iberian peninsula. This region is also de-
scribed as refuge area during the last glacial maximum 
20,000 years ago, from which repopulation of Europe took 
place. We speculate that a genetic bottleneck in the Iberian 
peninsula could have promoted the increased frequency of 
this haplotype by genetic drift. This hypothesis is supported 
by three arguments: (1) the West-East gradient of prevalence 
in the haplotype among European populations; (2) ancient 
DNA from Neolithic burials in the Iberian peninsula, dated 
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teria, viruses, fungi and protozoa by pattern recognition 
receptors (PRRs)  [3] . Several classes of PRRs have been 
described, among which the most studied are the Toll-
like receptors (TLRs)  [4] . The central role of TLRs for the 
host defense against infections is suggested by their large-
ly unchanged repertoire in all animal phyla (consisting of 
six major TLR classes)  [5] , and by their slow rate of evolu-
tion, most likely due to selection for conservation of func-
tion  [5, 6] . In addition to these phylogenetic data, evi-
dence has been provided that in  Homo sapiens , host de-
fense genes, and among them PRRs, are associated with 
recent selection events  [7, 8] .
 TLR4, encoded by the gene with the same name lo-
cated on chromosome 9, is the main receptor for the lipo-
polysaccharide component of Gram-negative bacteria. It 
also recognizes other pathogen-associated molecular 
patterns from mycobacteria, fungi, viruses and protozoa 
such as malaria  [9–13] . More than 35  TLR4 polymor-
phisms have been described, but most of them are in in-
trons or do not lead to changes in the structure of the 
molecule  [14] . However, two nonsynonymous single nu-
cleotide polymorphisms (SNPs) located in the extracel-
lular leucine-rich repeat domain of  TLR4 may result in 
differential ligand recognition: an A/G transition at SNP 
rs4986790 (896A/G) that causes an Asp/Gly amino acid 
change at position 299 of the molecule, and a C/T transi-
tion at SNP rs4986791 (1196C/T) that causes a Thr/Ile 
amino acid change at position 399 ( fig. 1 a). These muta-
tions affect the ligand-binding region (Asp299Gly) of 
TLR4 and the co-receptor binding region (Thr399Ile) of 
the receptor, respectively  [14] . It has been suggested that 
these  TLR4 polymorphisms have important functional 
consequences related to the induction of pro- and anti-
inflammatory cytokine production, and that they modu-
late the systemic inflammatory response syndrome in 
septic shock  [15] and influence susceptibility to Gram-
negative infections  [16] .
 Due to the modulation of cytokine production that 
may ensue in individuals bearing these  TLR4 polymor-
phisms, it has been proposed that  TLR4 Asp299Gly and 
Thr399Ile SNPs influence susceptibility to both infec-
tious and inflammatory diseases  [15, 17] , and that they 
may be therefore one factor explaining morbidity pat-
terns in different populations. In the present review we 
present an overview of the information pertaining to the 
prevalence of  TLR4 polymorphisms in various popula-
tions, and we propose a model explaining the distribution 
of  TLR4 polymorphisms in modern human populations 
on the European continent.
 Prevalence of  TLR4 Polymorphisms in Different 
Human Populations 
 The prevalence of  TLR4 alleles varies greatly between 
different populations around the world ( fig.  1 b; online 
suppl. table S1, www.karger.com/doi/10.1159/000329492). 
Based on the presence of Asp299Gly and Thr399Ile  TLR4 
polymorphisms in populations from both Africa and Eu-
rope, it is likely that these polymorphisms are ancient and 
occurred more than 65,000 years ago in Africa, before the 
migration of  Homo sapiens out of Africa and the separa-
tion of the populations from these two continents  [18] . 
Important differences have been described in the preva-
lence of  TLR4 alleles in various populations, possibly de-
pending on local infectious pressures and demographic 
history. The Asp299Gly SNP has a high prevalence in 
sub-Saharan Africa, and it has been proposed to have 
protective effects against mortality from malaria, al-
though the precise mechanisms of how this protection is 
mediated is not yet known  [19] . However, the  TLR4 hap-
lotype containing solely this mutation seems to have dis-
appeared from East Asians and Americans. In contrast, 
Asp299Gly has been found to be present in co-segrega-
tion with Thr399Ile, and this haplotype has a high preva-
lence especially in European populations  [19, 20] .
 The precise mechanisms that have led to these differ-
ences are still under investigation. On the one hand, evo-
lutionary processes driven by local infectious pressures 
could be one factor shaping the genetics of  TLR4 and the 
prevalence of the  TLR4 polymorphisms. On the other 
hand, neutral processes such as population migration 
and genetic drift may also have played an important role. 
One finding that may support this latter scenario is that 
of recent genetic studies showing a low number of fixed 
or nearly fixed genetic differences between human pop-
ulations. This pattern indicates that the selective pres-
sures encountered by the different populations are weak 
enough to allow nonselective forces such as genetic bot-
tlenecks and population history (including migration 
routes) to influence the genetic make-up  [21] . Genetic 
bottlenecks are encountered in certain periods or places 
during history when a population has gone through a 
significant decrease in number of individuals, either due 
to unfavorable conditions (for example, climatic change 
and epidemics of disease), or during migration of a small 
population to a new unpopulated area. It is well known 
that population bottlenecks strongly increase genetic 
drift.
 It is likely that both selective (infectious) pressures, de-
mographic history and genetic drift have played an im-
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portant role in the distribution of  TLR4 polymorphisms 
on the different continents. The main events of the colo-
nization of the world by the modern humans are repre-
sented by the exit out of Africa some 65,000 years ago, 
with subsequent complete colonization of Australia 
(50,000 years ago), Asia (40,000 years ago), Europe (35,000 
years ago) and the Americas (15,000 years ago)  [22] . The 
relatively high prevalence of the haplotype containing the 
Asp299Gly allele in sub-Saharan Africa suggests a pos-
sible beneficial role of this variant allele. Indeed, we have 
shown that individuals bearing this allele display a more 
efficient production of pro-inflammatory cytokines 
upon challenge with bacterial stimuli, and children bear-
ing the polymorphism are protected against cerebral ma-
TLR4 polymorphisms
Asp
299Gly
Thr
399Ile
LRR M TIR
1 2517
a
Wild type
299 allele
399 allele
299/399 allele
b
EUR
AFR
AS
AM
 Fig. 1.  a Genomic structure of the  TLR4  gene with the position of 
Asp299Gly and Thr399Ile indicated. LRR = Leucine-rich repeat 
domain; M = membrane domain; TIR = Toll/IL-1 receptor do-
main.  b World distribution of the  TLR4  haplotypes in human 
populations. Circles indicate average values of heterozygous and 
homozygous genotype frequencies combined per geographical 
region (white, wild-type; blue, 299Gly; yellow, 399Ile; red, 
299Gly/399Ile; colors in online version only). Exact frequency 
data are listed in online suppl. table S1. The 299Gly haplotype is 
concentrated in Africa, and the 299Gly/399Ile haplotype is con-
centrated in Europe. Arrows indicate the main out-of-Africa mi-
gration routes of modern  Homo sapiens . EUR = Europe, data 
based on populations from Spain (n = 107), the Netherlands (n = 
209), Germany (n = 632), Romania (n = 102), Greece (n = 162);
AS = Asia, data based on populations from China (n = 100), Indo-
nesia (n = 98) and Papua New Guinea (n = 49); AM = indigenous 
American populations, data based on a population from Surinam 
(n = 99); AFR = Africa, data based on populations from Mali (n = 
484), Cameroon (n = 142), Tanzania (n = 121), Sudan (n = 101). 
Adapted from Ferwerda et al. [19]. 
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laria  [19] . On the other hand, the demographic history 
has also likely influenced the distribution of  TLR4 poly-
morphisms: for example, indigenous populations of 
South America, living in hot climates for a relatively short 
period of time (last 10,000 years at most), originate from 
human populations that lived in the cold climates of 
North-East Asia for much longer before that, and these 
Asian populations lack any  TLR4 polymorphisms  [19] . 
The variant  TLR4 Asp299Gly genotype that protects 
against malaria has been probably lost during the 25,000-
year immigration to the Americas across the cold cli-
mates of North-East Asia, climates in which the  TLR4 
299Gly allele was likely deleterious due to increased mor-
tality from septic shock  [15] and possibly respiratory syn-
cytial virus  [23] .
 The Asp299Gly and Thr399Ile  TLR4 Alleles Are
Co-Segregated in Europe 
 The  TLR4 diversity in populations of the European 
continent, as in populations elsewhere, presents a par-
ticular profile. Interestingly, all studies to date have 
shown a very high level of co-segregation between the 
Asp299Gly and Thr399Ile polymorphisms in the Euro-
pean population, while the haplotypes containing either 
of the two polymorphisms alone are very rare, if present 
at all  [19, 20] . This is in fact not excessively surprising, if 
we have in mind the hierarchical temporal origin of the 
mutations (that is, the 399Ile mutation occurred in a 
299Gly allele) and assume that each site cannot mutate 
twice and that recombination is limited, because the rate 
is low or there has not been too much time for a substan-
tial recombination to happen. In this case, even if the re-
combination rate for the region is higher (6 cM/Mb) than 
the genome average (1 cM/Mb), the distance between 
both SNPs is not too long, so the effective recombination 
rate between the SNPs is proportional to the distance. Of 
course, even if the recombination rate is very low, after 
the passing of a substantial amount of time, recombina-
tions can occur. The question has been posed whether the 
prevalence of the Asp299Gly and Thr399Ile alleles (and 
especially of the haplotype containing both mutations) in 
the Eurasian landmass is mainly influenced by genetic 
drift and demographic history, as previously proposed 
 [19] , or whether yet to be described selective forces are at 
work.
 One approach to assess whether infections exerted se-
lective pressure on the  TLR4 variants is to investigate 
these polymorphisms in populations of different ethnic 
origins that for a long period of time lived in the same 
geographical location and under the same infectious 
pressure. One would expect that in case of strong infec-
tious pressure in populations of sufficient size, the preva-
lence of ancient polymorphisms such as the  TLR4 SNPs 
would become similar in the populations, irrespective of 
their ethnicity. We have recently performed an investiga-
tion of various polymorphisms and  TLR4 haplotypes in 
15 populations from Iran, a country ideal for such a study, 
considering its rich ethnic diversity and its key location 
on the routes of migration during the out-of-Africa hu-
man migration. In contrast to the homogeneity of the 
 TLR4 polymorphisms in other populations such as those 
from Africa or Europe, the Iranian subpopulations 
 display a broad heterogeneity of  TLR4 Asp299Gly and 
Thr399Ile, with all combinations of the  TLR4 SNPs pos-
sible being present in close geographical proximity [Ioana 
et al., in submission]. These findings suggest a weak or 
absent selection pressure on  TLR4 polymorphisms in the 
Middle East, supporting the hypothesis of genetic drift as 
the major force driving the prevalence of  TLR4 heteroge-
neity in Eurasian populations.
 In contrast to Iran, however, European populations 
are much more homogenous in terms of  TLR4 polymor-
phisms, the only variant haplotype being that in which 
Asp299Gly and Thr399Ile are co-segregated. Functional 
analysis of this haplotype did not show a major difference 
in the response of the variant TLR4 to pathogens, when 
compared with the wild-type haplotype  [19, 24] . On the 
one hand, these data, corroborated with the lack of evo-
lutionary pressures on  TLR4 SNPs suggested in Middle 
Eastern populations (see above), suggest that the distribu-
tion of  TLR4 polymorphisms in the European population 
is most likely the result of demography and genetic drift, 
rather than selection. On the other hand, the presence of 
just one variant  TLR4 haplotype suggests that this distri-
bution may be the result of a population bottleneck that 
promoted the increase in the prevalence of one variant 
haplotype in the ensuing population(s).
 It is difficult at present to demonstrate that this sce-
nario has indeed been the mechanism explaining the dis-
tribution of  TLR4 polymorphisms across Europe. How-
ever, there are indirect arguments that support the hy-
pothesis that the distribution of the  TLR4 299Gly/399Ile 
haplotype across Europe may be the result of a population 
bottleneck and subsequent genetic drift occurring in the 
Iberian refuge during the last glacial maximum (LGM) 
approximately 20,000 years ago.
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 TLR4 299Gly/399Ile Haplotype in the LGM
Iberian Refuge 
 Distribution of TLR4 SNP Prevalence in Various 
Populations across the Continent 
 Europe has been colonized by modern humans 
through several waves of migrants coming from the Mid-
dle East during the Upper Paleolithic and the Neolithic 
 [25] . Based on genetic data on both mitochondrial and Y-
chromosome DNA, the extant genetic pool of Europeans 
is believed to consist up to 80% of lineages from the Up-
per Paleolithic and only 20% from new arrivals during 
the Neolithic  [26, 27] . In addition, a key event in the pop-
ulation history of Europe has been caused by the harsh 
climatic changes occurring during the LGM.
 The early Paleolithic populations of Northern and 
Central Europe became extinct or retreated to the South, 
in several refuges in the Iberian, Italian and Balkan pen-
insula, a scenario supported by both archeological  [28] 
and genetic  [29] evidence ( fig. 2 a). After the retreat of the 
ice, an important population expansion from the Iberian 
and Balkan refuges, followed by the repopulation of Eu-
rope, has been proposed  [29] . Several studies on mito-
chondrial DNA have confirmed the Upper Paleolithic 
Iberian/Franco-Cantabrian refuge as a major source for 
the European gene pool  [30, 31] . Other authors have dis-
puted the exclusive role of the Franco-Cantabrian refuge 
as an origin of the South-Western recolonization of Eu-
rope, suggesting different local expansions with low ef-
fects on continental Europe  [32, 33] .
a
Wild type
299 allele
399 allele
299/399 allele
Ba NL Ge
Ro
Gr
18%
10%
4%
b
 Fig. 2.  a Geographical representation of the last glacial maximum 
era about 20,000 years BP with indicated the position of the ice 
cap and the refuge areas in the Iberian, Italian and Balkan penin-
sula.  b Distribution of the  TLR4  haplotypes in European human 
populations at present. Circles indicate average values of hetero-
zygous and homozygous genotype frequencies combined per geo-
graphical region (white, wild-type; blue, 299Gly; yellow, 399Ile; 
red, 299Gly/399Ile; colors in online version only). Exact frequen-
cy data are listed in online suppl. table S1. The 299Gly/399Ile hap-
lotype has a frequency of 18% in the Iberian peninsula which is 
diluted to 10% and 4% in Central European and South-Eastern 
European populations, respectively. Ba = Basque, Spain (n = 107); 
NL = The Netherlands (n = 209); Ge = Germany (n = 632); Ro = 
Romania (n = 102); Gr = Greece (n = 162). 
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 TLR4 polymorphisms have been most likely brought 
into Europe already in the Upper Paleolithic by the early 
modern human colonists. This assumption is based on 
the fact that the African population has a low 2–3% prev-
alence of the  TLR4 299Gly/399Ile co-segregated haplo-
type, and this most likely traveled with the first wave of 
migration out of Africa. However, the strong increase in 
the prevalence in later European populations may have 
had two sources: on the one hand, an increase in the prev-
alence in the Middle East and subsequent spread in Eu-
rope, a scenario that is, however, not supported by any 
evidence, or a later increase in prevalence in Europe. One 
scenario for this latter hypothesis is that the  TLR4 
299Gly/399Ile haplotype increased in frequency during 
the LGM in one of the South-European refuges as a result 
of the population bottleneck. The decreasing West-East 
gradient of  TLR4 299Gly/399Ile prevalence in European 
populations may support this second scenario: the high 
frequency of 18% of individuals bearing at least one allele 
of the  TLR4 299Gly/399Ile haplotype in Basque Country 
is diluted to 10% in Central European populations and 
down to 4% in South-Eastern European populations in 
Greece ( fig. 2 b; online suppl. table S1)  [19] , although one 
has to be careful with clines observed for alleles with rel-
atively low frequencies  [34] . This raises the possibility 
that the prevalence of the variant  TLR4 haplotype in-
creased in the LGM Iberian refuge, from which it spread 
throughout Europe during the recolonization of the con-
tinent, similar to the spread of several major lineages
of mitochondrial DNA such as haplogroup V and H  [28, 
30] .
 TLR4 Polymorphism in Ancient DNA Samples from 
the Iberian Peninsula 
 In order to provide additional arguments for this 
 hypothesis, we have investigated the presence of  TLR4 
polymorphisms in ancient samples from the Iberian pen-
insula. We have investigated 17 prehistoric samples, 12 
from the site of San Juan ante Portam Latinam, which is 
located in the province of Araba (Basque Country, Spain), 
and four additional samples that came from the site of 
Longar, a site located in the South of the province of Na-
varre (Spain) ( fig. 3 ).  14 C dating of human bone remains 
from these sites date the San Juan ante Portam Latinam 
site at approximately 5,000 years before present (BP), and 
that of Longar site at approximately 4,500 years BP. One 
additional sample corresponds to the remains of a wom-
an from the Mesolithic site of Aizpea (Navarre, Spain), 
which is dated at approximately 6,600 years BP. A de-
tailed description of the methodology and of the exten-
sive measures of avoiding contamination with modern 
DNA is presented in the supplementary information.
 When  TLR4 polymorphisms were assessed in these an-
cient DNA samples, we have identified two individuals 
heterozygous and one individual homozygous for the 
299Gly/399Ile  TLR4 haplotype, corresponding to 17% of 
individuals bearing at least one allele of the 299Gly/399Ile 
haplotype, very close to the prevalence of the polymor-
phism in the modern Basque population. In contrast, none 
of these ancient DNA samples showed the presence of ei-
ther Asp299Gly or Thr399Ile SNPs alone. One has to con-
cede that no definitive arguments can be provided that the 
DNA samples analyzed here mirror exactly the Upper Pa-
Longar
17 ancient DNA samples
6,600 to 4,500 years BP
complete TLR4 299/399 SNP linkage
San Juan
ante Portam
Latinam
Aizpea
 Fig. 3. Neolithic burial locations in the 
Basque Country. Circle indicates the fre-
quency of individuals bearing the 299G/ 
399I haplotype (red in the online version) 
in the Neolithic population from the Ibe-
rian peninsula. 
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leolithic populations of the Iberian refuge. However, this 
presumption is likely, because the samples analyzed here 
are from the beginning of the Neolithic period when agri-
culture had just been brought to the Iberian peninsula, 
and the Basque population is known to have the lowest 
prevalence of Neolithic genetic lineages  [29] . The high 
prevalence of the co-segregated  TLR4 299Gly/399Ile hap-
lotype in ancient DNA from the Iberian peninsula, espe-
cially reflected by the identification of an individual ho-
mozygous for this haplotype, supports the hypothesis of a 
population bottleneck in the Iberian isolated populations 
during the LGM as the source of the high prevalence of 
this  TLR4 haplotype in Western European populations.
 Conclusions 
 The overview data presented here show the variable 
distribution of  TLR4 polymorphisms among populations 
from the various continents. While there is little doubt 
that PRRs have evolved under selection driven by infec-
tions, the prevalence of polymorphisms in these recep-
tors, such as the Asp299Gly and Thr399Ile  TLR4 polymor-
phisms, depends on both their functional consequences 
for the function of the molecule, and on the history of the 
populations in which they are tested. In case of some  TLR4 
haplotypes, selection due to infectious pressures seems to 
have played an important role (the presence of Asp299Gly 
SNP in sub-Saharan Africa due to protection from ma-
laria), while in Europe the distribution of  TLR4 polymor-
phisms seems to have been shaped mainly by population 
migration and genetic drift. One plausible explanation for 
the high prevalence of the  TLR4 299Gly/399Ile haplotype 
in European populations might be the genetic drift occur-
ring in the isolated Upper Paleolithic populations in the 
Iberian refuge during the last LGM.
 Are there consequences of these differences in  TLR4 
polymorphisms for the modern human populations? Al-
though TLR4 has evolved as a pathogen receptor, a strong 
body of evidence accumulated during the past decade 
which supports its involvement in inflammatory and au-
toimmune processes as well. TLR4 can bind endogenous 
ligands (such as heat-shock proteins) that function as 
danger-associated molecular patterns and can thus initi-
ate sterile inflammation  [35] . In this manner, the host 
defense mechanisms that have beneficial effects during 
infection can be hijacked to exert deleterious effects of 
exaggerated inflammatory or autoimmune reactions 
 [36] . In this respect, it has been recently shown that  TLR4 
polymorphisms can increase the severity of atopy in pa-
tients with asthma  [37, 38] , or susceptibility to rheuma-
toid arthritis  [17] in European populations, and it can be 
hypothesized that similar processes are important for 
other autoimmune diseases as well. Thus, evolutionary 
processes that occurred long ago during the evolutionary 
history of  Homo sapiens still influence the susceptibility 
to disease in modern human populations.
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